Cambium Bio Limited (ASX:CMB)
Australia · Delayed Price · Currency is AUD 0.4500
0.00 (0.00%)
Apr 28, 2026, 3:10 PM AEST
Cambium Bio Market Cap
Cambium Bio has a market cap or net worth of 12.3 million as of April 29, 2026. Its market cap has increased by 126.57% in one year.
Market Cap
12.30M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.45
Market Cap Chart
Since April 5, 2024, Cambium Bio's market cap has increased from 7.97M to 12.30M, an increase of 54.37%. That is a compound annual growth rate of 23.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 12.30M | 13.93% |
| Dec 31, 2025 | 10.80M | 103.21% |
| Dec 31, 2024 | 5.31M | -33.33% |
| Apr 5, 2024 | 7.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Argenica Therapeutics | 22.48M |
| Algorae Pharmaceuticals | 22.25M |
| Patrys | 17.67M |
| Neurotech International | 15.81M |
| Bio-Gene Technology | 11.59M |
| AdAlta | 10.20M |
| Immuron | 10.13M |
| Tissue Repair | 8.77M |